ArticleFrontiers in cellular and infection microbiology2025
The combined 410nm and infrared light effectively suppresses bacterial survival under realistic conditions.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The demand for establishing an effective but inexpensive method to interfere with the spread of infectious diseases has been higher than ever before, since the recent pandemic. As a follow-up study, we tested a few practically applicable lights with a safe 410nm violet light (V) with infrared (IR, 850nm) under realistic conditions to identify an optimal light for suppressing pathogens. Our results indicate that 410nm violet light is as effective as the previously tested 405nm violet light with infrared (850nm). Therefore, we focused on optimizing combined lights (3V-1IR or 2.33V-1IR) with lower power level that is below 24 Watt. Using the Multi Drug Resistant (MDR)
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.